Pfizer challenges NICE drug approval decisions

Pfizer and its Japanese partner Eisai Co. are preparing for a court fight June 25 challenging the U.K.'s National Institute for Clinical Health and Excellence. The companies oppose NICE's process for approving or rejecting drugs for government subsidies. NICE argues it is only seeking good value for the money spent on drugs.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY